, Volume 17, Issue 4, pp 410–423 | Cite as

Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes

  • Ji Fang
  • Xiao-Wei Song
  • Jing Tian
  • Hu-Yan Chen
  • Dong-Feng Li
  • Jian-Fei Wang
  • An-Jing Ren
  • Wen-Jun Yuan
  • Li LinEmail author
Original Paper


MicroRNAs (miRNAs) are a novel class of powerful, endogenous regulators of gene expression. In an intact rat model of myocardial ischemia caused by coronary artery ligation, this study identified 17 miRNAs that changed more than 1.5-fold in the myocardium subjected to 4-h ischemia. Using miRNA microarray analysis, most of these aberrantly expressed miRNAs were confirmed by quantitative RT-PCR. MiR-378, a significantly down-regulated miRNA, was selected for further function study. In serum deprived rat H9c2 cardiomyocytes exposed to hypoxia (1% O2), miR-378 expression was down-regulated as well. The overexpression of miR-378 resulting from miR-378 mimic transfection significantly enhanced cell viability, reduced lactate dehydrogenase release, and inhibited apoptosis and necrosis. By contrast, miR-378 deficiency resulting from miR-378 inhibitor transfection aggravated the hypoxia-induced apoptosis and cell injury. In accordance, miR-378 inhibitor caused significant apoptosis and cell injury to cardiomyocytes cultured under normoxia. Using bioinformatic algorithms, caspase-3, a key apoptosis executioner, was predicted as a putative target of miR-378. The quantitative RT-PCR showed no effects of miR-378 mimic or inhibitor on caspase-3 mRNA level. However, the amount of caspase-3 proteins was reduced by miR-378 mimic, whereas increased by miR-378 inhibitor. Furthermore, the luciferase reporter assay confirmed caspase-3 to be a target of miR-378, and the apoptosis and cell injury caused by miR-378 inhibitor in both normoxic and hypoxic cells were abolished by a caspase-3 inhibitor. This study first showed that miR-378 inhibited caspase-3 expression and attenuated ischemic injury in cardiomyocytes. It may represent a potential novel treatment for apoptosis and ischemic heart disease.


MicroRNA Myocardial ischemia Hypoxia Apoptosis Cardiomyocytes 



This study was supported by grants from the National Basic Research Program of China (No. 2006CB503807, 2009CB521902), the National Natural Science Foundation of China (No. 30800375, 30870906, 31071023), the Pujiang Project of Shanghai, China (No. 08PJ14001), the Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China (No. [2008] 891), and the Fund for Outstanding Young Teachers in Higher Education Institutions of Shanghai, China (No. [2009] 63)

Conflict of interest

The authors confirm that there are no conflicts of interest.


  1. 1.
    Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297PubMedCrossRefGoogle Scholar
  2. 2.
    Bentwich I, Avniel A, Karov Y et al (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766–770PubMedCrossRefGoogle Scholar
  3. 3.
    Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120:21–24PubMedCrossRefGoogle Scholar
  4. 4.
    Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114PubMedCrossRefGoogle Scholar
  5. 5.
    Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233PubMedCrossRefGoogle Scholar
  6. 6.
    Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20PubMedCrossRefGoogle Scholar
  7. 7.
    Karp X, Ambros V (2005) Developmental biology. Encountering microRNAs in cell fate signaling. Science 310:1288–1289PubMedCrossRefGoogle Scholar
  8. 8.
    Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15:563–568PubMedCrossRefGoogle Scholar
  9. 9.
    Carè A, Catalucci D, Felicetti F et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nature Med 13:613–618PubMedCrossRefGoogle Scholar
  10. 10.
    Song XW, Li Q, Lin L et al (2010) MiRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes. J Cell Physiol 225:437–443PubMedCrossRefGoogle Scholar
  11. 11.
    Thum T, Galuppo P, Wolf C et al (2007) MicroRNAs in the human heart—a clue to fetal gene reprogramming in heart failure. Circulation 116:258–267PubMedCrossRefGoogle Scholar
  12. 12.
    Yang B, Lin H, Xiao J et al (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature Med 13:486–491PubMedCrossRefGoogle Scholar
  13. 13.
    Dong S, Cheng Y, Yang J et al (2009) MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284:29514–29525PubMedCrossRefGoogle Scholar
  14. 14.
    Hu S, Huang M, Li Z et al (2010) MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122:S124–S131PubMedCrossRefGoogle Scholar
  15. 15.
    Qian L, Van Laake LW, Huang Y et al (2011) miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 208:549–560PubMedCrossRefGoogle Scholar
  16. 16.
    Wang X, Zhang X, Ren XP et al (2010) MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122:1308–1318PubMedCrossRefGoogle Scholar
  17. 17.
    Mackman N (2008) Triggers, targets and treatments for thrombosis. Nature 451:914–918PubMedCrossRefGoogle Scholar
  18. 18.
    Downey JM, Cohen MV (2009) Why do we still not have cardioprotective drugs? Circ J 73:1171–1177PubMedCrossRefGoogle Scholar
  19. 19.
    Ye Y, Perez-Polo JR, Qian J et al (2011) The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol Genomics 43:534–542PubMedCrossRefGoogle Scholar
  20. 20.
    Lin L, Yuan WJ (2002) Effects of different preproendothelin-1 mRNA anti-sense oligodeoxynucleotides on ischemic arrhythmias in rats. J Cardiovasc Pharmacol 39:590–599PubMedCrossRefGoogle Scholar
  21. 21.
    Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J, Zhang C (2010) Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87:431–439PubMedCrossRefGoogle Scholar
  22. 22.
    Pan YX, Ren AJ, Zheng J et al (2007) Delayed cytoprotection induced by hypoxic preconditioning in cultured neonatal rat cardiomyocytes: role of GRP78. Life Sci 81:1042–1049PubMedCrossRefGoogle Scholar
  23. 23.
    Zheng J, Fang J, Yin YJ et al (2010) Leptin protects cardiomyocytes from serum-deprivation-induced apoptosis by increasing anti-oxidant defence. Clin Exp Pharmacol Physiol 37:955–962PubMedCrossRefGoogle Scholar
  24. 24.
    Martin SJ, Reutelingsperger CP, McGahon AJ et al (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545–1556PubMedCrossRefGoogle Scholar
  25. 25.
    Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39–51PubMedCrossRefGoogle Scholar
  26. 26.
    Hammill AK, Uhr JW, Scheuermann RH (1999) Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 251:16–21PubMedCrossRefGoogle Scholar
  27. 27.
    Krijnen PA, Sipkens JA, Molling JW, Rauwerda JA, Stehouwer CD, Muller A, Paulus WJ, van Nieuw Amerongen GP, Hack CE, Verhoeven AJ, van Hinsbergh VW, Niessen HW (2010) Inhibition of Rho–ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase. J Mol Cell Cardiol 49:781–790PubMedCrossRefGoogle Scholar
  28. 28.
    Xu C et al (2007) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120(Pt 17):3045–3052PubMedCrossRefGoogle Scholar
  29. 29.
    Rane S et al (2009) Downregulation of miR-199a derepresses hypoxia-inducible factor-alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104:879–886PubMedCrossRefGoogle Scholar
  30. 30.
    Bostjancic E, Zidar N, Stajer D, Glavac D (2010) MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115:163–169PubMedCrossRefGoogle Scholar
  31. 31.
    Bostjancic E, Zidar N, Stajner D, Glavac D (2010) MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction. Folia Biol 56:27–31Google Scholar
  32. 32.
    Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, Abdellatif M (2010) MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 285:20281–20290PubMedCrossRefGoogle Scholar
  33. 33.
    Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, Pritchard TJ, Fan GC (2009) MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119:2357–2366PubMedCrossRefGoogle Scholar
  34. 34.
    Roy S, Khanna S, Hussain SR et al (2009) MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82:21–29PubMedCrossRefGoogle Scholar
  35. 35.
    Porter AG, Jänicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6:99–104PubMedCrossRefGoogle Scholar
  36. 36.
    Woo M, Haken R, Soengas MS et al (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12:806–819PubMedCrossRefGoogle Scholar
  37. 37.
    Moissac D, Gurevich RM, Zheng H, Singal PK, Kirshenbaum LA (2000) Caspase activation and mitochondrial cytochrome c release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 32:53–63PubMedCrossRefGoogle Scholar
  38. 38.
    Pillai R, Bhattacharyya S, Filipowicz W (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17:118–126PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Ji Fang
    • 1
  • Xiao-Wei Song
    • 1
  • Jing Tian
    • 1
  • Hu-Yan Chen
    • 2
  • Dong-Feng Li
    • 1
  • Jian-Fei Wang
    • 2
  • An-Jing Ren
    • 1
  • Wen-Jun Yuan
    • 1
    • 2
  • Li Lin
    • 1
    Email author
  1. 1.Department of Physiology and the Key Laboratory of Molecular Neurobiology of Ministry of EducationSecond Military Medical UniversityShanghaiPeople’s Republic of China
  2. 2.Department of Physiology and NeurobiologyBasic Medical College, Ningxia Medical UniversityYinchuanPeople’s Republic of China

Personalised recommendations